• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer.

作者信息

Strong Roland K

机构信息

Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

出版信息

Mol Immunol. 2002 May;38(14):1029-37. doi: 10.1016/s0161-5890(02)00032-9.

DOI:10.1016/s0161-5890(02)00032-9
PMID:11955595
Abstract

Natural killer (NK) cells function through a diverse array of cell-surface natural killer receptors (NCRs). NCRs specific for classical and non-classical MHC class I proteins, expressed in complex patterns of inhibitory and activating isoforms on overlapping, but distinct, subsets of NK cells, play an important role in immunosurveillance against cells that have reduced MHC class I expression as a result of infection or transformation. Another NCR, NKG2D, is an activating NCR first identified on NK cells, but subsequently found on macrophages and a variety of T cell types. NKG2D ligands in rodents include the MHC class I-like proteins RAE-1 and H60 and, in humans, ULBPs and the cell stress-inducible proteins MICA and MICB. NKG2D-MIC and -RAE-1 recognition events have been implicated in anti-viral and -tumor immune responses. Crystallographic analyses of NKG2D-MICA and -RAE-1 complexes reveal an unusual mode of recognition that apparently tolerates a surprising degree of ligand plasticity while generating affinities that are among the strongest TCR- or NCR-ligand affinities, thus, far described.

摘要

相似文献

1
Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer.
Mol Immunol. 2002 May;38(14):1029-37. doi: 10.1016/s0161-5890(02)00032-9.
2
Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.Ly49I自然杀伤细胞受体的晶体结构揭示了Ly49家族中二聚化模式的变异性。
J Mol Biol. 2002 Jul 12;320(3):573-85. doi: 10.1016/s0022-2836(02)00498-9.
3
NKG2D and Related Immunoreceptors.自然杀伤细胞2D及相关免疫受体
Adv Protein Chem. 2004;68:281-312. doi: 10.1016/S0065-3233(04)68008-9.
4
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.NKG2D(一种应激诱导的MICA受体)对自然杀伤细胞和T细胞的激活作用。
Science. 1999 Jul 30;285(5428):727-9. doi: 10.1126/science.285.5428.727.
5
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.人类自然杀伤细胞2D(NKG2D)与其配体MICA、MICB以及小鼠RAE - 1蛋白家族同源物之间的相互作用。
Immunogenetics. 2001 May-Jun;53(4):279-87. doi: 10.1007/s002510100325.
6
Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.人类自然杀伤(NK)细胞上表达的主要组织相容性复合体(MHC)I类特异性受体的结构与功能。
Mol Immunol. 2002 Feb;38(9):637-60. doi: 10.1016/s0161-5890(01)00107-9.
7
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.激活型免疫受体NKG2D及其MHC I类样配体MICA的复杂结构
Nat Immunol. 2001 May;2(5):443-51. doi: 10.1038/87757.
8
The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.UL16结合蛋白是一类与NKG2D相关的新型MHC I类配体家族,可激活自然杀伤细胞功能。
Immunol Rev. 2001 Jun;181:185-92. doi: 10.1034/j.1600-065x.2001.1810115.x.
9
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.一种新型的NKG2D受体配体可激活自然杀伤细胞和巨噬细胞并诱导肿瘤免疫。
Eur J Immunol. 2003 Feb;33(2):381-91. doi: 10.1002/immu.200310012.
10
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?通过NKG2D激活淋巴细胞:迈向免疫识别的新范式?
Curr Opin Immunol. 2002 Jun;14(3):306-11. doi: 10.1016/s0952-7915(02)00337-0.

引用本文的文献

1
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands.激动型抗 NKG2D 抗体结构与天然配体相比具有独特的计量比和表位。
MAbs. 2024 Jan-Dec;16(1):2433121. doi: 10.1080/19420862.2024.2433121. Epub 2024 Nov 25.
2
Identification of small-molecule protein-protein interaction inhibitors for NKG2D.鉴定 NKG2D 的小分子蛋白-蛋白相互作用抑制剂。
Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2216342120. doi: 10.1073/pnas.2216342120. Epub 2023 Apr 25.
3
Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation.
NKG2D 配体及其受体在单倍体相合相关供者造血细胞移植中的作用。
Blood Adv. 2023 Jun 27;7(12):2888-2896. doi: 10.1182/bloodadvances.2022008922.
4
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.NKG2D应激配体的调控及其在癌症进展中的相关性
Cancers (Basel). 2022 May 9;14(9):2339. doi: 10.3390/cancers14092339.
5
NKG2D discriminates diverse ligands through selectively mechano-regulated ligand conformational changes.NKG2D 通过选择性地机械调节配体构象变化来区分不同的配体。
EMBO J. 2022 Dec 17;41(2):e107739. doi: 10.15252/embj.2021107739. Epub 2021 Dec 16.
6
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.双特异性抗体介导的 NKG2D-CAR 自然杀伤细胞重定向促进双重靶向并增强抗肿瘤活性。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-002980.
7
Role of immune cells in the removal of deleterious senescent cells.免疫细胞在清除有害衰老细胞中的作用。
Immun Ageing. 2020 Jun 3;17:16. doi: 10.1186/s12979-020-00187-9. eCollection 2020.
8
The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands.NKG2D 配体多态性的生物学影响和临床相关性。
Front Immunol. 2018 Aug 16;9:1820. doi: 10.3389/fimmu.2018.01820. eCollection 2018.
9
Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.靶向可溶性MICA的非阻断性单克隆抗体重塑内源性先天性和适应性抗肿瘤反应并消除原发性和转移性肿瘤。
Clin Cancer Res. 2015 Nov 1;21(21):4819-30. doi: 10.1158/1078-0432.CCR-15-0845. Epub 2015 Jun 23.
10
Cytomegalovirus microRNAs.巨细胞病毒微小核糖核酸
Curr Opin Virol. 2014 Aug;7:40-6. doi: 10.1016/j.coviro.2014.03.015. Epub 2014 Apr 23.